KardiaMobile is one of the most accurate consumer heart monitors available. It’s FDA-cleared to detect atrial fibrillation (AFib), the most common serious heart rhythm disorder, with sensitivity between 92% and 99% and specificity between 92% and 98% across four peer-reviewed studies. That puts it in a different league from most consumer health gadgets, though it has real limitations worth understanding before you buy.
What It Actually Detects
KardiaMobile records a medical-grade ECG (electrocardiogram) through your fingertips. You place two fingers from each hand on the device’s electrodes for 30 seconds, and the Kardia app on your phone displays the reading in real time. The built-in AI then classifies your recording as one of five results: normal sinus rhythm, atrial fibrillation, bradycardia (slow heart rate), tachycardia (fast heart rate), or unclassified.
The “unclassified” result is worth noting. It doesn’t mean something is wrong. It means the algorithm couldn’t confidently sort your reading into one of the other categories. This can happen from muscle movement during the recording, a loose finger placement, or a rhythm the software wasn’t trained to identify. If you’re sending your recordings to a doctor, even unclassified readings contain useful waveform data they can interpret.
What It Cannot Do
KardiaMobile cannot detect heart attacks. The Scottish Health Technologies Group states this plainly: the ECG it produces does not provide as much detail as a hospital ECG. A standard hospital ECG uses 12 leads placed across the chest and limbs to view the heart’s electrical activity from multiple angles. The basic KardiaMobile captures a single lead, roughly equivalent to Lead I of that 12-lead setup. The 6L model captures six leads, which is better but still not a replacement for a full clinical workup.
This distinction matters. If you’re having chest pain, shortness of breath, or other symptoms that could signal a cardiac emergency, a KardiaMobile reading that says “Normal” does not rule out a heart attack or other acute conditions. The device is designed for rhythm monitoring, not for diagnosing structural heart problems or blocked arteries.
Basic Model vs. 6L
AliveCor sells two main versions. The basic KardiaMobile records a single-lead ECG using two finger electrodes. It’s small enough to stick to the back of your phone or slip into a wallet. The KardiaMobile 6L adds a third electrode that rests against your knee or ankle, capturing six leads instead of one. Those extra leads give your doctor more information about the heart’s electrical activity from different angles, which can help identify certain abnormalities that a single lead would miss.
For most people buying the device to monitor for AFib, the single-lead version does the job. The 6L is more useful if your cardiologist has specifically asked you to capture more detailed recordings, or if you want richer data to share at appointments.
How It Compares to Apple Watch
A validation study published in JMIR Cardio found that the Apple Watch ECG provides information comparable to Lead I, the same single lead the basic KardiaMobile captures. In terms of raw detection ability for AFib, they’re in similar territory. The practical differences come down to how you use them.
The Apple Watch checks your heart rhythm passively in the background and alerts you if it detects an irregular pattern. KardiaMobile requires you to actively take a reading. That passive monitoring is genuinely useful for catching episodes of AFib that come and go without symptoms. On the other hand, KardiaMobile produces a cleaner ECG tracing because you’re holding still and focused during the recording. That cleaner signal is more useful when you need to share the result with a cardiologist. If you already own an Apple Watch, the built-in ECG may be sufficient for basic AFib screening. KardiaMobile is the better choice if you want higher-quality recordings or need the six-lead option.
Sharing Results With Your Doctor
Every recording can be exported as a PDF and emailed or printed for your doctor. This is one of KardiaMobile’s strongest features. The tracings look like what a cardiologist is trained to read, and many doctors find them genuinely useful for correlating symptoms with rhythm data between office visits.
AliveCor also offers a paid clinician review service through the app. After taking a recording, you can send it to a board-certified cardiologist who reviews it and returns a report, typically within about an hour. These reviewers can identify over 20 arrhythmias and observations beyond what the automated algorithm catches, including premature ventricular contractions (PVCs), premature atrial contractions (PACs), wide QRS patterns, and AV block. This service is included in some subscription tiers but costs extra on its own.
Subscription Costs and Free Features
The device works without a subscription for basic ECG recording and the automated AFib detection algorithm. You can take readings, see your results, and export PDFs without paying anything beyond the device price.
The KardiaCare subscription adds deeper features. At $99.99 per year (or $13.99 per month), you get advanced ECG analysis called KardiaAlert, unlimited cloud-stored recordings, summary reports, weight and medication tracking, and four free clinician ECG reviews per year. There’s also an AI-powered Q&A feature called AskKardia. The premium KardiaCare Plus tier costs $199 per year and adds automatic review of your first 20 abnormal recordings by a cardiologist, plus a free cardiologist consultation.
Whether the subscription is worth it depends on how often you record and whether you want professional eyes on your data. If you take a reading once a week and your doctor reviews them at regular appointments, the free tier is probably fine. If you’re actively managing a known arrhythmia and want frequent expert review, the subscription pays for itself compared to individual cardiologist review fees.
Battery and Day-to-Day Use
KardiaMobile runs on a single CR2016 coin cell battery, the flat kind you’d find in a watch or car key fob. It lasts about 200 hours of active recording time, which translates to roughly 12 months of typical use. When it dies, you pop it out and replace it yourself for a couple of dollars. There’s no charging cable to deal with, which is a genuine convenience for a device that’s supposed to always be ready when you feel a symptom.
The device connects to your phone via Bluetooth, and AliveCor maintains a long compatibility list covering iPhones back to the iPhone 6s, many iPads, and a wide range of Android phones from Google, Samsung, and others. That said, they do formally validate each phone model, so it’s worth checking their compatibility page before purchasing if you have an unusual or older device.
Who Benefits Most
KardiaMobile is most valuable for people in three situations. First, those with known or suspected AFib who want to capture episodes as they happen. AFib often comes and goes unpredictably, and having a recording of the actual event gives your doctor far more to work with than a normal ECG taken days later at the office. Second, people on medications for heart rhythm disorders who want to track whether their treatment is working. And third, people who experience occasional palpitations and want objective data to bring to their next appointment instead of trying to describe what they felt.
It’s less useful as a general-purpose health gadget. If you have no heart symptoms and no risk factors for AFib, the device will likely tell you “Normal” every time you use it, which isn’t particularly actionable information. The value scales directly with how much you need rhythm data between doctor visits.